Measure Title: Prevention of Arterial Line-Related Bloodstream Infections Description: Percentage of patients, regardless of age, who undergo placement of a peripheral intra-arterial catheter for whomContinue reading “2023 # AQI73 Prevention of Arterial Line-Related Bloodstream Infections”
QCDR Archive
2023 # ECPR39 Avoid Head CT for Patients with Uncomplicated Syncope
Measure Title: Avoid Head CT for Patients with Uncomplicated Syncope Description: Percentage of Adult Syncope Patients Who Did Not Receive a Head CT Scan Ordered byContinue reading “2023 # ECPR39 Avoid Head CT for Patients with Uncomplicated Syncope”
2023 # ECPR46 Avoidance of Opiate Prescriptions for Low Back Pain or Migraines
Measure Title: Avoidance of Opiate Prescriptions for Low Back Pain or Migraines Description: Percentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed anContinue reading “2023 # ECPR46 Avoidance of Opiate Prescriptions for Low Back Pain or Migraines”
2023 # ECPR51 Discharge Prescription of Naloxone after Opioid Poisoning or Overdose
Measure Title: Discharge Prescription of Naloxone after Opioid Poisoning or Overdose Description: Percentage of Opioid Poisoning or Overdose Patients Presenting to An Acute Care FacilityContinue reading “2023 # ECPR51 Discharge Prescription of Naloxone after Opioid Poisoning or Overdose”
2023 # ECPR52 Appropriate Treatment of Psychosis and Agitation in the Emergency Department
Measure Title: Appropriate Treatment of Psychosis and Agitation in the Emergency Department Measure Description: Percentage of Adult Patients With Psychosis or Agitation Who Were Ordered anContinue reading “2023 # ECPR52 Appropriate Treatment of Psychosis and Agitation in the Emergency Department”
2023 # ECPR55 Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain
Measure Title: Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain Measure Description: PercentageContinue reading “2023 # ECPR55 Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain”
2023 # ECPR56 Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment
Measure Title: Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment Measure Description: Percentage of Patients Presenting with Opioid Withdrawal Who WereContinue reading “2023 # ECPR56 Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment”
2023 # HCPR16 Physicians Orders for Life-Sustaining Treatment (POLST)
Measure Title: Physician’s Orders for Life-Sustaining Treatment (POLST) Form Measure Description: Percentage of Patients Greater Than or Equal to 65 Years of Age with Physician’s OrdersContinue reading “2023 # HCPR16 Physicians Orders for Life-Sustaining Treatment (POLST)”
2023 # HCPR17 Pressure Ulcers -Risk Assessment and Plan of Care
Measure Title: Pressure Ulcers – Risk Assessment and Plan of Care Measure Description: Percentage of Adult Post-acute Facility Patients That Had a Risk Assessment for PressureContinue reading “2023 # HCPR17 Pressure Ulcers -Risk Assessment and Plan of Care”
2023 # HCPR20 Clostridium Difficile- Risk Assessment and Plan of Care
Measure Title: Clostridium Difficile – Risk Assessment and Plan of Care Measure Description: Percentage of Adult Patients Who Had a Risk Assessment for C. difficile InfectionContinue reading “2023 # HCPR20 Clostridium Difficile- Risk Assessment and Plan of Care”